Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin

被引:94
|
作者
Reiter, RA
Knöbl, P
Varadi, K
Turecek, PL
机构
[1] Univ Vienna, Dept Med 1, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
[3] Baxter Bio Sci, Vienna, Austria
关键词
D O I
10.1182/blood-2002-03-0814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand factor-cleaving protease (ADAMTS13) cleaves von Willebrand factor (VWF) and regulates its physiologic function. To investigate the relation between ADAMTS13 activity and VWF, we compared ADAMTS13 activity with the VWF-related parameters VWF antigen (VWF:Ag), VWF collagen-binding activity (VWF:CBA), VWF-propeptide, proVWF, and VWF multimeric composition in 10 healthy volunteers and 3 patients with type 1 von Willebrand disease before and after infusing 0.3 mug/kg desmopressin. The VWF-related parameters in the volunteers increased 60 minutes after start of infusion by 3.7-fold for VWF:Ag, 7.2-fold for propeptide, and 2.2-fold for VWF: CBA. Unusually large VWF multimers and traces of proVWF appeared. The ADAMTS13 activity decreased to about half the initial value. After 24 hours values returned to baseline. Patients with type 1 von Wille-brand disease showed similar results. We conclude that the inverse correlation between ADAMTS13 and VWF-related parameters suggests a consumption of ADAMTS13 after the desmopressin-induced release of higher multimers of VWF. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:946 / 948
页数:3
相关论文
共 50 条
  • [41] Clinical Significance of von Willebrand Factor-Cleaving Protease (ADAMTS13) Deficiency in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
    Kim, Young Keun
    Lee, Jongwook
    Lee, Kyung-A
    Kwon, Hee Uk
    INFECTION AND CHEMOTHERAPY, 2009, 41 (02): : 78 - 81
  • [42] Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure
    Gombos, Timea
    Mako, Veronika
    Cervenak, Laszlo
    Papassotiriou, Jana
    Kunde, Jan
    Harsfalvi, Jolan
    Forhecz, Zsolt
    Pozsonyi, Zoltan
    Borgulya, Gabor
    Janoskuti, Livia
    Prohaszka, Zoltan
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (03) : 573 - 580
  • [43] Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
    Plaimauer, B.
    Hovinga, J. A. Kremer
    Juno, C.
    Wolfsegger, M. J.
    Skalicky, S.
    Schmidt, M.
    Grillberger, L.
    Hasslacher, M.
    Knoebl, P.
    Ehrlich, H.
    Scheiflinger, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (05) : 936 - 944
  • [44] The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants
    Schmugge, M
    Dunn, MS
    Amankwah, KS
    Blanchette, VS
    Freedman, J
    Rand, ML
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) : 228 - 233
  • [45] Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma:: a multicenter comparison of different assay methods
    Studt, JD
    Böhm, M
    Budde, U
    Girma, JP
    Varadi, K
    Lämmle, B
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) : 1882 - 1887
  • [46] Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children
    Chabchoub, R. Ben Abdallah
    Boukedi, A.
    BenSalah, M.
    Maalej, B.
    Gargour, L.
    Turk, F.
    Ben Halima, N.
    Wolf, M.
    Veyradier, A.
    Mahfoudh, A.
    ARCHIVES DE PEDIATRIE, 2013, 20 (08): : 853 - 857
  • [47] ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE
    McCabe, D. J. H.
    Starke, R.
    Harrison, P.
    Brown, M. M.
    Sidhu, P. S.
    Mackie, I. J.
    Machin, S. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 103 - 104
  • [48] AN UNEXPECTED ROLE OF THE VON WILLEBRAND FACTOR-CLEAVING PROTEASE ADAMTS-13 DURING EXPERIMENTAL INFLAMMATION IN LUNGS
    Bosmann, M.
    Alber, K.
    Falter, T.
    Jurk, K.
    Theobald, M.
    Scharrer, I.
    HAEMATOLOGICA, 2013, 98 : 197 - 197
  • [49] Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates
    Strauss, T.
    Elisha, N.
    Ravid, B.
    Rosenberg, N.
    Lubetsky, A.
    Levy-Mendelovich, S.
    Morag, I.
    Goettl, U. Nowak
    Kenet, G.
    BLOOD CELLS MOLECULES AND DISEASES, 2017, 67 : 14 - 17
  • [50] Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome
    Veyradier, A
    Obert, B
    Haddad, E
    Cloarec, S
    Nivet, H
    Foulard, M
    Lesure, F
    Delattre, P
    Lakhdari, M
    Meyer, D
    Girma, JP
    Loriat, C
    JOURNAL OF PEDIATRICS, 2003, 142 (03): : 310 - 317